Delivery Order SPE2DB25D3108-SPE2DB26FPBJP
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,343.04 on September 17, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units). This competitively awarded, firm fixed-price contract carries no set-aside designation and is scheduled for completion by September 18, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) valued at $3,328.77. This firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a non-competitive delivery against AmerisourceBergen's larger indefinite delivery contract with DLA. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) with a ceiling value of $2,511.68. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. As a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count packages) valued at $3,508.43. This contract utilizes a firm fixed-price structure with an ultimate completion date of September 26, 2025, and was awarded on a competitive basis without any set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,179.32 to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (60 count) on August 26, 2025, with a completion date of August 27, 2025. This competitively awarded, firm fixed-price delivery order was placed without a set-aside designation and represents a routine pharmaceutical procurement to support federal medical supply needs. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $16,224.45 to AmerisourceBergen Drug Corp for 180 tablets of Janumet XR 50-1,000 mg on September 16, 2025, with a completion date of September 17, 2025. This competitively awarded, firm fixed-price contract involves pharmaceutical delivery to support federal medical procurement needs. The contract was fulfilled by AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) under a firm fixed-price arrangement. The $9,811.62 delivery order, which represents a non-set-aside competitive award, is scheduled for completion by September 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order through its established...
- The Defense Logistics Agency awarded a delivery order valued at $4,193.47 to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (180-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) valued at $8,599.50. This competitive award, issued without set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at approximately $1 billion...
- The Defense Logistics Agency (DLA) awarded a $17,575.18 delivery order to AmerisourceBergen Drug Corp for the supply of Janumet XR 100-1,000 mg tablets (90-count units) under a firm fixed-price contract. The award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, delivered the pharmaceutical product to its corporate office...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB26FPBJPDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,659.77 for Janumet XR 50-1,000 mg tablets (180-count units) on October 21, 2025, with an ultimate completion date of October 22, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order supports the Defense Health Agency and federal military healthcare systems through AmerisourceBergen's comprehensive pharmaceutical prime vendor arrangement. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen fulfills a wide range of medical supply needs for military and veteran healthcare programs globally, including brand-name and generic medications, vaccines, and specialized medical supplies. The underlying IDC structure enables flexible ordering of pharmaceutical products across multiple therapeutic domains to support Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/21/25 |